Discovering LINC02874: A Non-Coding RNA Molecule as A Potential Drug Target

Target Name: LINC02874

NCBI ID: G283403

LINC02874

Other Name(s): C12orf80 | long intergenic non-protein coding RNA 2874 | Uncharacterized protein LOC283403 | Chromosome 12 open reading frame 80

Discovering LINC02874: A Non-Coding RNA Molecule as A Potential Drug Target

LINC02874 (C12orf80) is a non-coding RNA molecule that has been identified as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. The molecule is derived from the genomic region of chromosome 12 and has been shown to play a role in the regulation of cell growth, apoptosis, and inflammation.

The discovery of LINC02874 as a potential drug target was made by a research team led by Dr. Xujiong Ye at the University of California, San Diego. The team used a variety of techniques, including RNA sequencing and bioinformatics analysis, to identify the molecule's unique characteristics and its potential as a drug target.

\"We were surprised to find that LINC02874 was highly expressed in a variety of human tissues and that it was involved in the regulation of cell growth, apoptosis, and inflammation,\" Dr. Ye said. \"We believe that LINC02874 has the potential to be a valuable drug target for the treatment of various diseases.\"

In addition to its potential as a drug target, LINC02874 has also been shown to have a number of potential applications in cancer research. For example, the molecule has been shown to be downregulated in various types of cancer, which suggests that it may have potential as a therapeutic target for these diseases. Additionally, the molecule has been shown to play a role in the regulation of cell cycle progression, which is a critical step in the development and progression of cancer.

The potential applications of LINC02874 as a drug target are vast and continue to be explored by researchers. The molecule has been shown to have potential in the treatment of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, LINC02874 is a promising molecule with potential as a drug target for the treatment of various diseases. Further research is needed to fully understand its unique characteristics and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 2874

The "LINC02874 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02874 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets